Chemo-proteomics reveals dihydrocaffeic acid exhibits anti-inflammation effects via Transaldolase 1 mediated PERK-NF-κB pathway
Cell Communication and Signaling · 2025
DOI: 10.1186/s12964-024-01958-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Communication and Signaling, 2025. Verfasst von Guanjun Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen key Laboratory of Kidney Diseases, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical…. Hauptthemen laut MEDLINE: NF-kappa B, Anti-Inflammatory Agents, Caffeic Acids, Proteomics. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Acute pneumonia is a kind of widespread inflammatory pathological process. Dihydrocaffeic acid (DA), metabolite of chlorogenic acid, possesses potent pharmacologic activity for the therapy of a wide range of disorders and various biological properties, such as anti-inflammation. Nevertheless, the specific protein targets and potential molecular mechanisms of DA in acute pneumonia are still poorly understood. PURPOSE: To investigate the anti-inflammation effects of DA and its target and its specific mechanisms. METHODS: Here, we conducted lipopolysaccharides (LPS)-induced acute pneumonia model mice. Besides, the activity-based protein profiling (ABPP) was performed to explore the potential targets of DA. Furthermore, cellular thermal shift assay (CETSA) and pulldown-western blot assays were used to validate the conclusion. RESULTS: In this study, we indicated that DA alleviated acute pneumonia in mice and displayed excellent anti-inflammatory efficacy in vivo and in vitro. Besides, we discovered DA binds directly to transaldolase 1(TALDO1) and influenced its enzymatic activity, and identified the specific cysteine sites Cys250. Also we demonstrated that DA reveals anti-inflammation effect through TALDO1 mediated PERK-IκBα-NF-κB pathway in RAW 264.7 cells. CONCLUSION: This study provide support for the potential advancement of DA for use as a therapeutic agent for the treatment of acute pneumonia and inflammation-associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen key Laboratory of Kidney Diseases, Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatric, Shenzhen People's Hospital (The Second…
- Dongguan Maternal and Child Health Care Hospital, Postdoctoral Innovation Practice Base of Southern Medical University, Dongguan, 523129, China.
- National Clinical Research Center for Chinese Medicine Cardiology, Academy of Chinese Medical Sciences, Xiyuan Hospital, Beijing, China.
- State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, P.R. China.
- Center for Drug Research and Development, Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, Guangdong Pharmaceutical University, Guangzhou, 510006, P. R. China. xw7688@smu.e…
- School of Traditional Chinese Medicine, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, Guangdong, China. dqfsmu7@126.com.
Förderung
- the National Key Research and Development Program of China
- the National Natural Science Foundation of China
Zitieren
APA
Li, G., Li, H., Wang, P., Zhang, X., Kuang, W., Huang, L., Zhang, Y., Xiao, W., Du, Q., Tang, H., & Wang, J. (2025). Chemo-proteomics reveals dihydrocaffeic acid exhibits anti-inflammation effects via Transaldolase 1 mediated PERK-NF-κB pathway. Cell Communication and Signaling. https://doi.org/10.1186/s12964-024-01958-3
Vancouver
Li G, Li H, Wang P, Zhang X, Kuang W, Huang L, et al. Chemo-proteomics reveals dihydrocaffeic acid exhibits anti-inflammation effects via Transaldolase 1 mediated PERK-NF-κB pathway. Cell Communication and Signaling. 2025. doi:10.1186/s12964-024-01958-3
BibTeX
@article{Li2025,
author = {Li, Guanjun and Li, Huiying and Wang, Peili and Zhang, Xinzhou and Kuang, Wenhua and Huang, Ling and Zhang, Ying and Xiao, Wei and Du, Qingfeng and Tang, Huan and Wang, Jigang},
title = {Chemo-proteomics reveals dihydrocaffeic acid exhibits anti-inflammation effects via Transaldolase 1 mediated PERK-NF-κB pathway},
journal = {Cell Communication and Signaling},
year = {2025},
doi = {10.1186/s12964-024-01958-3}
}
EUVIMED